Dr. Shy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-8753Fax+1 319-384-7199
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1981 - 1982
- Albany Medical CenterInternship, Internal Medicine, 1979 - 1980
- Albany Medical CollegeClass of 1979
Certifications & Licensure
- NY State Medical License 1982 - Present
- IA State Medical License 2012 - 2025
- MI State Medical License 1994 - 2013
- PA State Medical License 1986 - 1994
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others Start of enrollment: 2010 Apr 01
- Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 Start of enrollment: 2010 May 01
- Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B.Thierry Touvier, Francesca A Veneri, Anke Claessens, Cinzia Ferri, Rosa Mastrangelo
Brain. 2025-02-21 - Generation of two induced pluripotent stem cell lines from Charcot-Marie-Tooth type 1B patients harboring autosomal dominant mutations in myelin protein zero gene.Jingting Zhu, Gongbo Guo, Fatemeh Mehryab, Mary Kate McCulloch, Wilson Marques Junior
Stem Cell Research. 2025-02-15 - Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD.Andrea Cortese, Maike F Dohrn, Riccardo Curro, Sara Negri, Petra Lassuthova
Brain. 2025-02-13
Journal Articles
- Development and Validation of the Charcot-Marie-Tooth Disease Infant ScaleMichael E Shy, Rosemary Shy, Gyula Acsadi, Brain
Press Mentions
- Investigational Treatment Promising for SORD DeficiencyJuly 5th, 2024
Grant Support
- Genomic Studies In Charcot-Marie-Tooth DiseaseNational Institute Of Neurological Disorders And Stroke2012
- TrainingNational Institute Of Neurological Disorders And Stroke2009–2011
- Natural HistoryNational Institute Of Neurological Disorders And Stroke2009–2011
- Inherited Neurophathies Consortium (RDCRC)National Institute Of Neurological Disorders And Stroke2009–2011
- Early And LATE Onset CMT1BNational Institute Of Neurological Disorders And Stroke2006–2010
- Genotype Phenotype Correlation In CMTXNational Institute Of Neurological Disorders And Stroke2003–2006
- Adhesion And Gene Expression In CMT1BNational Institute Of Neurological Disorders And Stroke2001–2004
- Third International Research Symposium On CMT DisordersNational Institute Of Neurological Disorders And Stroke1998
- Antibodies To Gangliosides GM1 And GD1BNational Institute Of Neurological Disorders And Stroke1989–1992
- Antibodies To Gangliosides GM1 &Gd1b &Their EffectsNational Institute Of Neurological Disorders And Stroke1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: